| 1 |
33081115 | Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC). | 2020 Oct 16 |
1 |
| 2 |
28753113 | A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab. | 2018 May |
1 |
| 3 |
26179905 | NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation. | 2015 Aug 15 |
2 |
| 4 |
24311787 | Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies. | 2014 Feb 7 |
1 |
| 5 |
24662005 | Immunoglobulin GM and FcγRIIIa genotypes influence cytotoxicity of neuroblastoma cells. | 2014 May 15 |
1 |
| 6 |
24701371 | Genetic variants of IgG1 antibodies and FcγRIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells. | 2014 Jan 1 |
1 |
| 7 |
25230857 | Pyrosequencing for classification of human FcγRIIIA allotypes: a comparison with PCR-based techniques. | 2014 Dec |
3 |
| 8 |
23379433 | Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. | 2013 Mar |
1 |
| 9 |
23680410 | Detection of the FCGR3a polymorphism using a real-time polymerase chain reaction assay. | 2013 Apr |
1 |
| 10 |
23871153 | Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer. | 2013 Oct |
1 |
| 11 |
19401346 | In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma. | 2009 May 15 |
2 |
| 12 |
18179643 | Simple genotyping of functional polymorphisms of the human immunoglobulin G receptors CD16A and CD32A: a reference cell panel. | 2008 Mar |
1 |
| 13 |
17875730 | Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. | 2007 Sep 15 |
2 |
| 14 |
15659493 | Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia. | 2005 Jan 20 |
3 |
| 15 |
16181633 | Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism. | 2005 Nov 30 |
1 |
| 16 |
14563637 | Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia. | 2004 Feb 15 |
1 |
| 17 |
15037082 | Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. | 2004 Mar 5 |
1 |
| 18 |
12799050 | Rapid single-step FCGR3A genotyping based on SYBR Green I fluorescence in real-time multiplex allele-specific PCR. | 2003 Jun 1 |
4 |
| 19 |
9242542 | Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. | 1997 Aug 1 |
2 |
| 20 |
2531919 | Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. | 1989 Dec 22 |
2 |